Drug Shortage Report for ETOPOSIDE INJECTION USP
| Report ID | 65767 |
| Drug Identification Number | 02380935 |
| Brand name | ETOPOSIDE INJECTION USP |
| Common or Proper name | ETOPOSIDE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 25ML X 1VIAL |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-12-17 |
| Estimated end date | 2022-06-27 |
| Actual end date | 2022-07-13 |
| Shortage status | Resolved |
| Updated date | 2022-07-14 |
| Company comments | Product is no longer marketed |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2022-07-14 | English | Compare |
| v27 | 2022-07-13 | French | Compare |
| v26 | 2022-07-13 | English | Compare |
| v25 | 2019-12-06 | French | Compare |
| v24 | 2019-12-06 | English | Compare |
| v23 | 2019-12-05 | French | Compare |
| v22 | 2019-12-05 | English | Compare |
| v21 | 2019-11-19 | French | Compare |
| v20 | 2019-11-19 | English | Compare |
| v19 | 2019-11-06 | French | Compare |
| v18 | 2019-11-06 | English | Compare |
| v17 | 2019-03-07 | French | Compare |
| v16 | 2019-03-07 | French | Compare |
| v15 | 2019-03-07 | English | Compare |
| v14 | 2019-02-04 | French | Compare |
| v13 | 2019-02-04 | English | Compare |
| v12 | 2019-01-08 | French | Compare |
| v11 | 2019-01-08 | English | Compare |
| v10 | 2018-12-18 | English | Compare |
| v9 | 2018-12-17 | French | Compare |